Record overview
Status and phase
Status: COMPLETED
Phase: PHASE2
Sponsor: Verrica Pharmaceuticals Inc.
Condition: Basal Cell Carcinoma, Skin Cancer, Cancer of the Skin, Basal Cell, Cancer of the Skin, Carcinoma
NCT05188729
Open-Label Proof of Concept Study of VP-315 in Basal Cell Carcinoma
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Low Signal
Timeline signals: stale_update_signal
Results signal: Low Signal
Operational burden: strict_eligibility_signal
Stopped reason
Context when available
No stop reason available in the current public record.